PATTERNS OF CARE FOR LUNG CANCER IN RADIATION ONCOLOGY DEPARTMENTS OF TURKEY

dc.authoridYalman, Deniz/0000-0002-4010-8353
dc.authoridAksu, Melek Gamze/0000-0001-9146-2531
dc.authoridOzyigit, Gokhan/0000-0002-7497-4348
dc.authoridALICIKUS, Zumre ARICAN/0000-0002-5445-6797
dc.authoridNALCA ANDRIEU, MELTEM/0000-0001-7897-8445
dc.authoridDemiral, Ayse/0000-0003-0388-676X
dc.authorwosidyavuz, ali aydin/C-3154-2016
dc.authorwosidYalman, Deniz/ABG-5077-2020
dc.authorwosidkilciksiz, Sevil/Y-7790-2018
dc.authorwosidAksu, Melek Gamze/C-2284-2016
dc.authorwosidALICIKUS, LUTFIYE ZUMRE ARICAN/Q-2090-2019
dc.authorwosidalicikus, zumre arican/AAM-1051-2020
dc.authorwosidKOC, MEHMET/B-3319-2008
dc.contributor.authorDemiral, Ayse Nur
dc.contributor.authorAlicikus, Zuemre Arican
dc.contributor.authorUgur, Vahide Isil
dc.contributor.authorKaradogan, Ilker
dc.contributor.authorYoeney, Adnan
dc.contributor.authorAndrieu, Meltem Nalca
dc.contributor.authorYalman, Deniz
dc.date.accessioned2024-08-04T20:31:05Z
dc.date.available2024-08-04T20:31:05Z
dc.date.issued2008
dc.departmentİnönü Üniversitesien_US
dc.description25th Congress of the European-Society-for-Therapeutic-Radiology-and-Oncology -- OCT 08-12, 2006 -- Leipzig, GERMANYen_US
dc.description.abstractPurpose: To determine the patterns of care for lung cancer in Turkish radiation oncology centers. Methods and Materials: Questionnaire forms from 21 of 24 (87.5%) centers that responded were evaluated. Results: The most frequent histology was non-small cell lung cancer (NSCLC) (81%). The most common postoperative radiotherapy (RT) indications were close/(+) surgical margins (95%) and presence of pN2 disease (91%). The most common indications for postoperative chemotherapy (CHT) were >= IB disease (19%) and the presence of pN2 disease (19%). In Stage IIIA potentially resectable NSCLC, the most frequent treatment approach was neoadjuvant concomitant chemoradiotherapy (CHRT) (57%). In Stage IIIA unresectable and Stage IIIB disease, the most frequent approach was definitive concomitant CHRT (91%). In limited SCLC, the most common treatment approach was concomitant CHRT with cisplatin+etoposide for cycles 1-3, completion of CHT to cycles 4-6, and finally prophylactic cranial irradiation in patients with complete response (71%). Six cycles of cisplatin + etoposide CHT and palliative thoracic RT, when required, was the most commonly used treatment (81%) in extensive SCLC. Sixty-two percent of centers did not have endobronchial brachytherapy (EBB) facilities. Conclusion: There is great variation in diagnostic testing, treatment strategies, indications for postoperative RT and CHT, RT features, and EBB availability for LC cases. To establish standards, national guidelines should be prepared using a multidisciplinary approach. (c) 2008 Elsevier Inc.en_US
dc.description.sponsorshipEuropean Soc Therapeut Radiol & Oncolen_US
dc.identifier.doi10.1016/j.ijrobp.2008.03.035
dc.identifier.endpage1537en_US
dc.identifier.issn0360-3016
dc.identifier.issn1879-355X
dc.identifier.issue5en_US
dc.identifier.pmid18707825en_US
dc.identifier.scopus2-s2.0-56349123023en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage1530en_US
dc.identifier.urihttps://doi.org/10.1016/j.ijrobp.2008.03.035
dc.identifier.urihttps://hdl.handle.net/11616/94698
dc.identifier.volume72en_US
dc.identifier.wosWOS:000261214600037en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofInternational Journal of Radiation Oncology Biology Physicsen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectPatterns of careen_US
dc.subjectLung canceren_US
dc.subjectRadiation oncologyen_US
dc.subjectRadiotherapyen_US
dc.subjectChemotherapyen_US
dc.titlePATTERNS OF CARE FOR LUNG CANCER IN RADIATION ONCOLOGY DEPARTMENTS OF TURKEYen_US
dc.typeConference Objecten_US

Dosyalar